Usability and Acceptability Study of the P-STEP Mobile Application
| 대상 질환 | Asthma, Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Coronary Heart Disease |
|---|---|
| 임상 단계 | 단계 해당 없음 |
| 스폰서 | University of Leicester |
| 상태 | 완료 |
| 참여자 수 | 178 명 |
| 중재(약물) | P-STEP Mobile Application |
| 시작일 | 2023년 8월 23일 |
| 완료일 | 2024년 2월 1일 |
| 결과 공개일 | 2026년 5월 1일 |
요약
Assess the usability and acceptance of the P-STEP app, through allowing participants with specific chronic conditions to pilot the app for 12-weeks.
System Usability Scale
| 6-weeks | 57.92 ± 20.12 score on a scale |
|---|---|
| 12-week | 61.68 ± 22.09 score on a scale |
BENITIONS에서 보기 ClinicalTrials.gov 원문 보기
같은 질환의 다른 임상
- Feasibility, Safety and Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and — University of Tennessee Graduate School of Medicine
- Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate Versus Foster — Chiesi Farmaceutici S.p.A.
- Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®T — Chiesi Farmaceutici S.p.A.
- Tiotropium/Salmeterol Inhalation Powder in COPD — Boehringer Ingelheim
- Risk Factors, Costs, and Impacts of ED Boarding — University of Maryland, Baltimore
- Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructiv — United Therapeutics